# Source: Carterra Official Website

**Type:** source
**Status:** Useful
**Confidence:** Medium
**Source Type:** official-page
**URL:** https://carterra-bio.com/
**Archive:** https://web.archive.org/web/20260517032530/https://carterra-bio.com/
**Archived:** 2026-05-17
**Publisher:** Carterra, Inc.
**Raw:** raw/carterra-official-website/2026-08-11-d2eb4e49ed29.txt
**Retrieved:** 2026-08-12
**Updated:** 2026-08-11

## Summary

Carterra's corporate homepage describing its high-throughput surface plasmon resonance platforms for antibody screening and characterization.

## Useful Claims

- Carterra lists a Salt Lake City street address on its homepage footer.
- The homepage markets Carterra LSA, LSA XT, Ultra, and Vega instruments for high-throughput kinetics, epitope binning, and related antibody-discovery workflows.
- Customer testimonials on the homepage name pharmaceutical and biotech users of the LSA platform; the page does not name a headcount or founding year.

## Verbatim

> "825 N. 300 W. Ste. C309 Salt Lake City, UT 84103"
> — Home page footer

> "LSA and LSA XT can test 1152 ligands against several antigens in one unattended run"
> — Home page, throughput section

> "To match our capacity in generating antibody libraries, we use the Carterra LSA for screening and characterization."
> — Aaron Sato, PhD, Chief Scientific Officer, Biopharma, Twist Bioscience (customer testimonial)

## Reliability Notes

Self-reported marketing site. Instrument specifications and customer quotes describe how the company positions its products; they are not independent validation of performance claims.

## Related Pages

- [Carterra](carterra.md)